Institutional investors adjust stakes in Eli Lilly and SELLAS Life Sciences

Recent SEC filings reveal significant shifts in institutional holdings for Eli Lilly and Company and SELLAS Life Sciences Group, Inc.

Sapient Capital LLC increased its stake in Eli Lilly and Company by 0.2% during the second quarter, bringing its total ownership to 1,447,540 shares. This position, valued at approximately $1.74 billion, represents about 22.7% of Sapient Capital’s total holdings, making Eli Lilly its largest holding. Other investors, including Shira Ridge Wealth Management and Allied Private Wealth LLC, also established or modified positions in the company during the same period.

In the first quarter, Bank of New York Mellon Corp increased its holdings in SELLAS Life Sciences Group, Inc. by 86.6%. The firm now owns 478,366 shares, valued at approximately $2.02 million. Other institutional activity includes Dagco Inc. growing its position by 78.1% and Axxcess Wealth Management LLC increasing its stake by 121.1%.